CA1194483A - Furyloxazolylacetic acid derivatives and processes for preparing same - Google Patents
Furyloxazolylacetic acid derivatives and processes for preparing sameInfo
- Publication number
- CA1194483A CA1194483A CA000422117A CA422117A CA1194483A CA 1194483 A CA1194483 A CA 1194483A CA 000422117 A CA000422117 A CA 000422117A CA 422117 A CA422117 A CA 422117A CA 1194483 A CA1194483 A CA 1194483A
- Authority
- CA
- Canada
- Prior art keywords
- group
- compound
- furyl
- carbon atoms
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Obesity (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57030921A JPS58148882A (ja) | 1982-02-26 | 1982-02-26 | フリルオキサゾリル酢酸誘導体及びその製法 |
| JP30921/1982 | 1982-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1194483A true CA1194483A (en) | 1985-10-01 |
Family
ID=12317149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000422117A Expired CA1194483A (en) | 1982-02-26 | 1983-02-22 | Furyloxazolylacetic acid derivatives and processes for preparing same |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4642313A (enExample) |
| EP (1) | EP0087782B1 (enExample) |
| JP (1) | JPS58148882A (enExample) |
| KR (1) | KR900001423B1 (enExample) |
| AT (1) | ATE19879T1 (enExample) |
| BG (1) | BG39977A3 (enExample) |
| CA (1) | CA1194483A (enExample) |
| DE (1) | DE3363575D1 (enExample) |
| DK (1) | DK82583A (enExample) |
| ES (1) | ES520136A0 (enExample) |
| HK (1) | HK87188A (enExample) |
| HU (1) | HU193648B (enExample) |
| SG (1) | SG10688G (enExample) |
| SU (1) | SU1169536A3 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59152382A (ja) * | 1983-02-18 | 1984-08-31 | Tanabe Seiyaku Co Ltd | フリルオキサゾリル酢酸誘導体 |
| SE9302332D0 (sv) * | 1993-07-06 | 1993-07-06 | Ab Astra | New compounds |
| AU682792B2 (en) * | 1994-10-13 | 1997-10-16 | Cv Therapeutics, Inc. | Method of manufacturing non-absorbable synthetic sulfated polysaccharides |
| US7071174B1 (en) | 1994-10-13 | 2006-07-04 | Cv Therapeutics, Inc. | Method and composition for inhibiting cholesterol esterase |
| WO2002083111A2 (en) * | 2001-04-16 | 2002-10-24 | Tanabe Seiyaku Co., Ltd. | Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE32084B1 (en) * | 1967-06-07 | 1973-04-04 | Wyeth John & Brother Ltd | Thiazole derivatives |
| FI53314C (fi) * | 1967-06-14 | 1978-04-10 | Wyeth John & Brother Ltd | Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid) |
| GB1245087A (en) * | 1967-10-26 | 1971-09-02 | Wyeth John & Brother Ltd | Heterocyclic compounds |
| US3578671A (en) * | 1967-11-06 | 1971-05-11 | Wyeth John & Brother Ltd | Oxazoles |
| FR2068418A1 (en) * | 1969-10-27 | 1971-08-27 | Innothera Lab Sa | 2-substd-5-amino isoxazole derivs |
| AR208400A1 (es) * | 1974-03-13 | 1976-12-27 | Yoshitomi Pharmaceutical | Un metodo para producir nuevos acidos 5-alcoxi-4-oxazolalcanoicos 2-substituidos y sus esteres |
| JPS51110039A (ja) * | 1975-02-28 | 1976-09-29 | Yoshitomi Pharmaceutical | Ketsuchushishitsutaishakaizenzai |
| GB1542315A (en) * | 1976-08-13 | 1979-03-14 | Wyeth John & Brother Ltd | Process for preparing oxazoles |
| JPS5677268A (en) * | 1979-11-28 | 1981-06-25 | Yoshitomi Pharmaceut Ind Ltd | Oxazoleacetic acid derivative |
| JPS57188587A (en) * | 1981-05-15 | 1982-11-19 | Tanabe Seiyaku Co Ltd | Thienyloxazolylacetic acid derivative and its preparation |
-
1982
- 1982-02-26 JP JP57030921A patent/JPS58148882A/ja active Granted
-
1983
- 1983-02-10 US US06/465,544 patent/US4642313A/en not_active Expired - Fee Related
- 1983-02-22 CA CA000422117A patent/CA1194483A/en not_active Expired
- 1983-02-23 DK DK82583A patent/DK82583A/da not_active Application Discontinuation
- 1983-02-24 BG BG059855A patent/BG39977A3/xx unknown
- 1983-02-25 DE DE8383101872T patent/DE3363575D1/de not_active Expired
- 1983-02-25 ES ES520136A patent/ES520136A0/es active Granted
- 1983-02-25 SU SU833555401A patent/SU1169536A3/ru active
- 1983-02-25 KR KR1019830000770A patent/KR900001423B1/ko not_active Expired
- 1983-02-25 AT AT83101872T patent/ATE19879T1/de active
- 1983-02-25 EP EP83101872A patent/EP0087782B1/en not_active Expired
- 1983-02-25 HU HU83658A patent/HU193648B/hu not_active IP Right Cessation
-
1988
- 1988-02-06 SG SG106/88A patent/SG10688G/en unknown
- 1988-10-27 HK HK871/88A patent/HK87188A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US4642313A (en) | 1987-02-10 |
| HU193648B (en) | 1987-11-30 |
| ES8403891A1 (es) | 1984-04-01 |
| HK87188A (en) | 1988-11-04 |
| DK82583D0 (da) | 1983-02-23 |
| JPS58148882A (ja) | 1983-09-05 |
| KR840003632A (ko) | 1984-09-15 |
| SU1169536A3 (ru) | 1985-07-23 |
| JPS635027B2 (enExample) | 1988-02-01 |
| EP0087782A1 (en) | 1983-09-07 |
| KR900001423B1 (ko) | 1990-03-09 |
| DE3363575D1 (en) | 1986-06-26 |
| EP0087782B1 (en) | 1986-05-21 |
| SG10688G (en) | 1988-07-01 |
| ES520136A0 (es) | 1984-04-01 |
| BG39977A3 (en) | 1986-09-15 |
| ATE19879T1 (de) | 1986-06-15 |
| DK82583A (da) | 1983-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7211591B2 (en) | Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient | |
| EP1737809B1 (en) | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders | |
| JPWO1999046232A1 (ja) | カルボン酸誘導体およびその誘導体を有効成分として含有する薬剤 | |
| JP2007533722A (ja) | トリ（シクロ）置換アミド化合物 | |
| JP2001526278A (ja) | アリールチアゾリジンジオン誘導体 | |
| US6821994B2 (en) | Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient | |
| CA1194483A (en) | Furyloxazolylacetic acid derivatives and processes for preparing same | |
| US5116855A (en) | Rhodanine derivatives and pharmaceutical compositions | |
| US7241784B2 (en) | Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient | |
| US4942236A (en) | 2-aryl substituted pyridyl-containing phenyl sulfonamido compounds as antiallergic and antiinflammatory agents | |
| US4001280A (en) | Chromone derivatives | |
| US4460596A (en) | Thienyloxazolylacetic acid derivatives and process for preparing | |
| WO1996005820A1 (en) | Hyperlipemia remedy | |
| US4535089A (en) | Alkyloxazolylacetic acid derivative for the treatment of hyperlipidemia | |
| US4230719A (en) | Novel 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid and pharmaceutically acceptable salt thereof and method for treating symptoms of inflammation and pain | |
| JPH08325264A (ja) | 新規２−芳香環置換−３−フェニルプロピオン酸またはアクリル酸誘導体 | |
| EP0120270B1 (en) | Furyloxazolylacetic acid derivative, processes for preparing same and pharmaceutical composition | |
| JPH0449548B2 (enExample) | ||
| JPS59172488A (ja) | 抗脂血剤 | |
| JPWO2001014350A1 (ja) | 置換ベンジルチアゾリジン−２，４−ジオン誘導体 | |
| JP2005035998A (ja) | ビスラクトン誘導体及びその医薬組成物としての使用 | |
| MXPA06009793A (en) | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders | |
| JPWO2001014349A1 (ja) | 置換ベンジルチアゾリジン−２，４−ジオン誘導体 | |
| JPWO2000023442A1 (ja) | カルボン酸誘導体およびその誘導体を有効成分として含有する薬剤 | |
| JPWO2000012491A1 (ja) | カルボン酸誘導体およびその誘導体を有効成分として含有する薬剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEC | Expiry (correction) | ||
| MKEX | Expiry |